Tuberculosis vaccine research: the impact of immunology.
about
Genome-wide screen for Mycobacterium tuberculosis genes that regulate host immunityRecombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus MacaquesA nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungsLysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosisPreclinical evidence for implementing a prime-boost vaccine strategy for tuberculosisA review of the literature on the economics of vaccination against TB.Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.The immunology of tuberculosis: from bench to bedside.Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T CellsSuboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo.Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in miceRv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection.Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection.Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytesMycobacterium tuberculosis directs immunofocusing of CD8+ T cell responses despite vaccinationImmunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B.Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes.Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.Human leukocyte antigen class 1 genotype distribution and analysis in persons with active tuberculosis and household contacts from Central Uganda.Enhanced anti-tuberculosis immunity by a TAT-Ag85B protein vaccine in a murine tuberculosis model.The current state of tuberculosis vaccinesDesign and Construction of a Cloning Vector Containing the hspX Gene of Mycobacterium tuberculosis.Synthesis and structural insight into ESX-1 Substrate Protein C, an immunodominant Mycobacterium tuberculosis-secreted antigen.Recurrent tuberculosis: relapse, reinfection, and HIV.Production and Purification of Mycolyl Transferase B of Mycobacterium tuberculosis.Construction of a Novel DNA Vaccine Candidate Encoding an HspX-PPE44-EsxV Fusion Antigen of Mycobacterium tuberculosis.Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity.A study on the immune response induced by a DNA vaccine encoding Mtb32C-HBHA antigen of Mycobacterium tuberculosis.Reasons for optimism in the search for new vaccines for tuberculosis.New Aspects in Immunopathology of Mycobacterium tuberculosis
P2860
Q27313489-EBB16C29-BC01-413E-8459-91FE26F08CBAQ27491052-D0B83421-3FDA-41EE-A499-503131FC7459Q28396228-23FFCFAA-D643-4B3B-83F6-6C4C52A1D09FQ28476716-5BECEF88-969A-4B33-AACD-545532E06826Q28730427-A70B9D53-6458-4A18-A8D1-552E22C8248EQ30413692-5FD7E6A8-0B4E-48AF-A065-FEBBB8B72B14Q33737428-DF77E665-B92C-4317-8713-5481F819C52BQ33777367-8B424D39-A6EF-4FA5-AD69-600DEF063816Q33900380-48D0283C-E9D9-4584-B661-FD5A8DAB7E60Q33921252-44D837F9-4A92-4100-BF14-58BB5CBA451AQ34309667-A3166D65-43F0-4974-9A6F-1F84507E15AFQ34804956-408D6C04-BD0B-4177-BEFE-4AEBA43191FCQ34840811-B3ED6F0B-E791-4388-B716-E9CBE0231598Q34983762-45EBE7CC-7AEA-4B8B-9474-C8FC72F263F0Q34983782-9B37E497-54A8-4891-9EB3-A79A67BBB65BQ35097333-3111405D-75C4-4B9D-8A62-0AC4847F94E0Q35915369-9AF986DE-0320-4029-B4E4-3838E5495332Q35987898-568D8C93-FF04-4A21-9EA7-041FEDF2D9E9Q36038717-3E70E3D8-6F1A-43F3-8F92-FFDA83125FF3Q36141802-64BACD2C-7377-4BB1-938C-D4EDA99CDB58Q36733309-D26FBC0B-E068-4287-B7D6-3C019C94E7C9Q38116351-7DD9253E-B18C-469B-88A6-DD62BCA71011Q38772529-045253DB-9A09-4B31-8921-6E5F2AB84610Q39901819-56223D16-F8B3-42CF-8416-684F1AD117EBQ42076385-3BB3AA2F-6B17-4336-87CA-471E3EE49267Q42272975-399DF496-450F-4762-A6E6-4425A3ACF492Q42354327-32C8FC8B-2A74-447D-AF2A-F08A47B77B86Q43514266-A584CE68-3FE9-4884-94C5-C9881662B77CQ47131991-2E825F5B-ED96-4611-80EE-DC3B6D4163B9Q47327109-BF5F2B1F-318A-430A-81E8-18BED839DB17Q58905565-AE124B2E-516E-4127-B6E4-004C47232CAB
P2860
Tuberculosis vaccine research: the impact of immunology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tuberculosis vaccine research: the impact of immunology.
@en
Tuberculosis vaccine research: the impact of immunology.
@nl
type
label
Tuberculosis vaccine research: the impact of immunology.
@en
Tuberculosis vaccine research: the impact of immunology.
@nl
prefLabel
Tuberculosis vaccine research: the impact of immunology.
@en
Tuberculosis vaccine research: the impact of immunology.
@nl
P2093
P1476
Tuberculosis vaccine research: the impact of immunology.
@en
P2093
Jerald C Sadoff
Lewellys F Barker
Michael J Brennan
Peri K Rosenstein
P304
P356
10.1016/J.COI.2009.05.017
P577
2009-06-07T00:00:00Z